Singapore markets close in 2 hours

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.3600+0.0300 (+9.09%)
At close: 04:00PM EST
0.3515 -0.01 (-2.36%)
After hours: 07:57PM EST
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
-251,906
-264,524
-369,212
-400,424
-368,009
Depreciation & amortisation
7,712
8,496
8,198
7,768
4,601
Deferred income taxes
0
-
-
0
0
Stock-based compensation
23,975
25,453
50,794
54,304
49,090
Change in working capital
29,559
30,271
11,957
8,329
-55,202
Accounts receivable
4,323
-746
-5,407
-7,518
-3,371
Inventory
17,654
12,574
5,321
-26,160
-49,936
Accounts payable
-4,749
736
-5,852
12,289
5,770
Other working capital
-175,841
-196,369
-261,082
-342,655
-430,239
Other non-cash items
3,876
4,247
38,087
25,605
2,178
Net cash provided by operating activities
-175,575
-196,057
-252,728
-323,615
-365,997
Cash flows from investing activities
Investments in property, plant and equipment
-266
-312
-8,354
-19,040
-64,242
Purchases of investments
-
0
-9,962
-459,835
-500,000
Sales/maturities of investments
-
0
144,644
621,998
300,000
Net cash used for investing activities
-266
-312
126,328
143,398
-264,242
Cash flows from financing activities
Debt repayment
0
-65,411
-166,124
-1,275
-280
Common stock issued
31,564
116,924
246,668
0
93,890
Net cash used provided by (used for) financing activities
66,346
100,157
203,644
119,888
388,464
Net change in cash
-113,629
-96,801
78,396
-60,043
-242,322
Cash at beginning of period
171,949
240,229
161,833
221,876
464,198
Cash at end of period
62,454
143,428
240,229
161,833
221,876
Free cash flow
Operating cash flow
-175,575
-196,057
-252,728
-323,615
-365,997
Capital expenditure
-266
-312
-8,354
-19,040
-64,242
Free cash flow
-175,841
-196,369
-261,082
-342,655
-430,239